The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 safety study of SBP-101, a polyamine metabolic inhibitor, for pancreatic ductal adenocarcinoma (PDA).
 
Niall C. Tebbutt
Honoraria - Amgen; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Roche
 
Dusan Kotasek
No Relationships to Disclose
 
Mitesh J. Borad
Stock and Other Ownership Interests - Gilead Sciences; GlaxoSmithKline
Consulting or Advisory Role - Agios (Inst); ArQule (Inst); Celgene (Inst); Fujifilm (Inst); G1 Therapeutics; Halozyme (Inst); Inspyr Therapeutics; Insys Therapeutics (Inst); Novartis (Inst); TD2
Research Funding - Agios (Inst); ARIAD (Inst); BiolineRx (Inst); Boston Biomedical (Inst); Celgene (Inst); Dicerna (Inst); Eisai (Inst); EMD Serono (Inst); Halozyme (Inst); ImClone Systems (Inst); Incyte (Inst); Isis Pharmaceuticals (Inst); MedImmune (Inst); miRNA Therapeutics (Inst); Senhwa Biosciences (Inst); Sillajen (Inst); Sun Biopharma (Inst); Sun BioPharma (Inst); Taiho Pharmaceutical (Inst); Threshold Pharmaceuticals (Inst); Toray Industries (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Celgene
 
Erkut Hasan Borazanci
Consulting or Advisory Role - Biogen (I); Fujifilm; Genzyme (I); Ipsen; Novartis (I); Teva (I)
Speakers' Bureau - Biogen (I); Genzyme (I); Ipsen; Novartis (I); Taiho Pharmaceutical; Teva (I)
Research Funding - Ambry Genetics (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Idera (Inst); Lilly (Inst); MabVax (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst); Samumed (Inst)
 
Sheri Lynn Smith
Stock and Other Ownership Interests - 3M; Sun BioPharma
Consulting or Advisory Role - Clinigen Group (Inst); Humanetics (Inst); IGF Oncology (Inst); Medtronic (Inst); Sun Biopharma (Inst); Tolero Pharmaceuticals (Inst); Vanquish Oncology (Inst)
 
Ajit K. Shah
Employment - Sun BioPharma
Stock and Other Ownership Interests - Sun BioPharma
Consulting or Advisory Role - Sun BioPharma
Patents, Royalties, Other Intellectual Property - Sun Biopharma
Travel, Accommodations, Expenses - Sun BioPharma
 
Michael J Walker
Employment - Sun BioPharma
Stock and Other Ownership Interests - Abbvie (I); Johnson & Johnson; Novocure (I); Sun BioPharma
Consulting or Advisory Role - Sun BioPharma
Research Funding - Sun BioPharma
Patents, Royalties, Other Intellectual Property - Sun Biopharma
 
Michael T. Cullen
Employment - Sun Biopharma
Leadership - Sun BioPharma
Stock and Other Ownership Interests - Sun BioPharma
 
Suzanne Gagnon
Employment - Sun BioPharma
Leadership - Sun BioPharma
Stock and Other Ownership Interests - Sun BioPharma